Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)
Clinical trial NCT06390826 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06390826
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2023-04-05
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.